← FDA Drug Approvals (Drugs@FDA)
APREPITANT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMACEUTICALS INC · Approved 2025-11-17
Drug application
- FDA Application #
ANDA216976- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- APREPITANT
- Generic name
- Aprepitant
- Active ingredients
- APREPITANT
- Dosage form
- INJECTION, EMULSION
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN PHARMACEUTICALS INC
- First approval
- 2025-11-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown